Eptifibatide contains the main ingredient Eptifibatide with a concentration of 0.75mg/1ml - a platelet aggregation inhibitor, belonging to the RGD-like subgroup (Arginine Glycine - Aspartate). It is used to treat patients with acute coronary syndromes or undergoing percutaneous coronary intervention (PCI).